Van Strum & Towne’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.05M | Hold |
85,044
| – | – | 0.56% | 45 |
|
|
2026
Q1 | $2.39M | Sell |
85,044
-400
| -0.5% | -$10.6K | 0.7% | 42 |
|
|
2025
Q4 | $2.13M | Buy |
85,444
+750
| +0.9% | +$18.9K | 0.6% | 44 |
|
|
2025
Q3 | $2.16M | Sell |
84,694
-840
| -1% | -$20.7K | 0.63% | 41 |
|
|
2025
Q2 | $2.07M | Sell |
85,534
-50
| -0.1% | -$1.17K | 0.65% | 39 |
|
|
2025
Q1 | $2.17M | Buy |
85,584
+15,900
| +23% | +$416K | 0.73% | 35 |
|
|
2024
Q4 | $1.85M | Buy |
69,684
+3,655
| +6% | +$99.1K | 0.65% | 37 |
|
|
2024
Q3 | $1.91M | Buy |
66,029
+625
| +1% | +$18.2K | 0.66% | 38 |
|
|
2024
Q2 | $1.83M | Hold |
65,404
| – | – | 0.66% | 35 |
|
|
2024
Q1 | $1.81M | Buy |
65,404
+720
| +1% | +$20K | 0.66% | 34 |
|
|
2023
Q4 | $1.86M | Buy |
64,684
+3,175
| +5% | +$96K | 0.73% | 34 |
|
|
2023
Q3 | $2.04M | Hold |
61,509
| – | – | 0.86% | 33 |
|
|
2023
Q2 | $2.26M | Buy |
61,509
+336
| +0.5% | +$13.1K | 0.93% | 31 |
|
|
2023
Q1 | $2.51M | Sell |
61,173
-434
| -0.7% | -$18.7K | 1.07% | 27 |
|
|
2022
Q4 | $3.16M | Sell |
61,607
-350
| -0.6% | -$16.8K | 1.36% | 24 |
|
|
2022
Q3 | $2.71M | Sell |
61,957
-75
| -0.1% | -$3.64K | 1.25% | 24 |
|
|
2022
Q2 | $3.25M | Sell |
62,032
-50
| -0.1% | -$2.55K | 1.39% | 24 |
|
|
2022
Q1 | $3.21M | Buy |
62,082
+59
| +0.1% | +$3.06K | 1.2% | 26 |
|
|
2021
Q4 | $3.66M | Sell |
62,023
-300
| -0.5% | -$14.9K | 1.33% | 24 |
|
|
2021
Q3 | $2.68M | Sell |
62,323
-300
| -0.5% | -$13.3K | 1.06% | 26 |
|
|
2021
Q2 | $2.45M | Buy |
62,623
+490
| +0.8% | +$19.1K | 1.17% | 24 |
|
|
2021
Q1 | $2.25M | Hold |
62,133
| – | – | 1.14% | 25 |
|
|
2020
Q4 | $2.29M | Buy |
62,133
+1,883
| +3% | +$69.1K | 1.27% | 22 |
|
|
2020
Q3 | $2.1M | Sell |
60,250
-574
| -0.9% | -$20.1K | 1.36% | 22 |
|
|
2020
Q2 | $1.89M | Sell |
60,824
-304
| -0.5% | -$10.3K | 1.31% | 22 |
|
|
2020
Q1 | $1.89M | Buy |
61,128
+764
| +1% | +$26K | 1.5% | 21 |
|
|
2019
Q4 | $2.24M | Hold |
60,364
| – | – | 1.38% | 24 |
|
|
2019
Q3 | $2.06M | Buy |
60,364
+1,787
| +3% | +$65K | 1.36% | 24 |
|
|
2019
Q2 | $2.41M | Hold |
58,577
| – | – | 1.71% | 21 |
|
|
2019
Q1 | $2.36M | Sell |
58,577
-1,054
| -2% | -$42.2K | 1.76% | 23 |
|
|
2018
Q4 | $2.47M | Buy |
59,631
+416
| +0.7% | +$17.3K | 2.08% | 19 |
|
|
2018
Q3 | $2.48M | Hold |
59,215
| – | – | 1.6% | 26 |
|
|
2018
Q2 | $2.04M | Sell |
59,215
-226
| -0.4% | -$7.72K | 1.41% | 26 |
|
|
2018
Q1 | $2M | Sell |
59,441
-1,202
| -2% | -$41.3K | 1.41% | 26 |
|
|
2017
Q4 | $2.08M | Sell |
60,643
-1,238
| -2% | -$42.2K | 1.39% | 27 |
|
|
2017
Q3 | $2.1M | Sell |
61,881
-4,533
| -7% | -$146K | 1.36% | 28 |
|
|
2017
Q2 | $2.12M | Sell |
66,414
-1,791
| -3% | -$56.5K | 1.38% | 30 |
|
|
2017
Q1 | $2.21M | Sell |
68,205
-2,952
| -4% | -$93.1K | 1.43% | 30 |
|
|
2016
Q4 | $2.19M | Hold |
71,157
| – | – | 1.38% | 30 |
|
|
2016
Q3 | $2.29M | Sell |
71,157
-748
| -1% | -$25K | 1.5% | 30 |
|
|
2016
Q2 | $2.4M | Sell |
71,905
-738
| -1% | -$23.6K | 1.6% | 28 |
|
|
2016
Q1 | $2.04M | Sell |
72,643
-2,073
| -3% | -$59.2K | 1.35% | 32 |
|
|
2015
Q4 | $2.29M | Hold |
74,716
| – | – | 1.48% | 31 |
|
|
2015
Q3 | $2.23M | Hold |
74,716
| – | – | 1.52% | 32 |
|
|
2015
Q2 | $2.38M | Sell |
74,716
-812
| -1% | -$26.5K | 1.46% | 31 |
|
|
2015
Q1 | $2.49M | Sell |
75,528
-2,803
| -4% | -$89.1K | 1.55% | 31 |
|
|
2014
Q4 | $2.31M | Buy |
78,331
+3,981
| +5% | +$114K | 1.43% | 29 |
|
|
2014
Q3 | $2.09M | Buy |
74,350
+1,279
| +2% | +$35.9K | 1.36% | 30 |
|
|
2014
Q2 | $2.06M | Sell |
73,071
-790
| -1% | -$22.5K | 1.34% | 31 |
|
|
2014
Q1 | $2.25M | Sell |
73,861
-1,739
| -2% | -$51.9K | 1.45% | 32 |
|
|
2013
Q4 | $2.2M | Sell |
75,600
-3,315
| -4% | -$96.5K | 1.47% | 33 |
|
|
2013
Q3 | $2.15M | Sell |
78,915
-855
| -1% | -$23.3K | 1.6% | 30 |
|
|
2013
Q2 | $2.12M | Buy |
+79,770
| New | +$2.2M | 1.63% | 29 |
|
Other funds holding PFE
Van Strum & Towne's PFE Position: Q2 2026 in Review
Van Strum & Towne held its Pfizer (PFE) position steady in Q2 2026 at 85,044 shares worth $2.05M. The position accounts for 0.56% of the portfolio, ranked #45.
Van Strum & Towne first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.66M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Van Strum & Towne held 85,044 shares of Pfizer worth $2.05M as of Q2 2026.
- Van Strum & Towne left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.56% of Van Strum & Towne's portfolio in Q2 2026, its #45 holding.
- Van Strum & Towne first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Van Strum & Towne's Pfizer position peaked at $3.66M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Van Strum & Towne's 13F filing for Q2 2026, filed 3 Aug 2026.